Financials
- Financial year
- 2025
- Total assets
- €426,561
- Loss
- -€68,317
- Solvency
- -38.9%
Total assets▼ 7.2%
Net result
20182025
Vereenooghe SEW
ActiveSummary
The computed 12-month bankruptcy probability of Vereenooghe SEW is 4.9% (elevated). The 2025 annual accounts show negative equity (-€165,760) and a net result of -€68,317. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 6% of 5,014 sector peers (NACE 47, financial year 2025). The company has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€426,561total assets 2025
- Staff
- 2 FTE
- Equity
- -€165,760
- Loss
- -€68,317
Structure
- Parent
- Matel Consult & Construct · 99.92%
- BV MATEL CONSULT & CONSTRUCTManaging director · permanent representative Yves Van Cauwenberghe
- Caroline VereenoogheDirector
2025 accounts 15 days early1 of 4 deeds summarised
Why 35raises riskNegative equity -€165,760Loss of €68,317, the second in a row (financial year 2025)Sector: Retail trade (NACE 47)lowers riskSize: 2 FTE, total assets €426,561Show the evidence
Checked score
Score 2025
35
/ 100
Weak
Probability in this band: 4.2% to 15.0%
Financially better than 6% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency
0-4
equity -38.9% of total assets
Liquidity
2=
short-term debt 138.9% · cash 1.7%
Profitability
0=
return on assets -16.0%
Bankruptcy probability, 12 months
4.9%
Elevated
0%0.5%1.5%4%10%≥ 25%
About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 1.8%
12-2024: 1.0%▼ -0.8 percentage points vs 11-2024
01-2025: 1.0%● unchanged vs 12-2024
02-2025: 1.0%● unchanged vs 01-2025
03-2025: 1.0%● unchanged vs 02-2025
04-2025: 1.0%● unchanged vs 03-2025
05-2025: 1.0%● unchanged vs 04-2025
06-2025: 1.0%● unchanged vs 05-2025lowest value
07-2025: 1.2%▲ +0.2 percentage points vs 06-2025
08-2025: 1.5%▲ +0.3 percentage points vs 07-2025
09-2025: 1.7%▲ +0.2 percentage points vs 08-2025
10-2025: 2.1%▲ +0.4 percentage points vs 09-2025
11-2025: 6.8%▲ +4.7 percentage points vs 10-2025highest value
12-2025: 6.8%● unchanged vs 11-2025highest value
01-2026: 6.8%● unchanged vs 12-2025highest value
02-2026: 6.8%● unchanged vs 01-2026highest value
03-2026: 6.7%▼ -0.1 percentage points vs 02-2026
04-2026: 6.7%● unchanged vs 03-2026
05-2026: 6.5%▼ -0.2 percentage points vs 04-2026
06-2026: 6.3%▼ -0.2 percentage points vs 05-2026
07-2026: 6.5%▲ +0.2 percentage points vs 06-2026
08-2026: 4.9%▼ -1.6 percentage points vs 07-2026
09-2026: 4.9%● unchanged vs 08-2026
10-2026: 4.9%● unchanged vs 09-2026
No credit on open account
Liquidity insufficient (current ratio 0.69, compared with 0.79 in 2024, below 1; short-term debt: 138.9% and cash: 1.7% of total assets), and equity is negative.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 6% on solvency, 4% on liquidity, 6% on profitability and 8% on growth.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€165,760
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
15 days early
2024
70 days late
2023
92 days late
2022
70 days late
2021
39 days late
2020
89 days late
2019
84 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 61 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 October (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · full…
- Reappointments: Caroline Vereenooghe (director) and BV…Permanent representative: Yves Van Cauwenberghe…
- Annual accounts filedfinancial year 2024 · abbreviated…
Key points
- Risk: Negative equityfinancial year 2025: debts exceed assets -€165,760 View
- Risk: 4 loss-making years in a rowloss financial year 2025 -€68,317 View
- Caution: Among the weakest 6% on solvencysector median 36.1% · 5,014 companies -38.9% View
- Caution: Equity fell in 2025from -€97,443 to -€165,760 ▼ 70.1% View
- Controlled by Matel Consult & Construct 99.92% View
By topic
Board & ownership
- Board
- 2 members
- Parent
- Matel Consult & Construct · 99.92%
- BV MATEL CONSULT & CONSTRUCTManaging director
- Caroline VereenoogheDirector
Timeline
- Events
- 39
- Since
- 1992
- Next accounts
- by 31-07-2027
- 31-12-2024Weakest financial year
- 31-10-2024Annual accounts filed
- 09-10-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 15-10-1990
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Key facts about Vereenooghe SEW
- What is the company number of Vereenooghe SEW?
- 0442.615.651. In Belgium the VAT number is the company number with BE in front: BE 0442.615.651.
- Where is Vereenooghe SEW based?
- The registered office is at Sint-Hubrechtsplein 1, 8880 Ledegem.Company details
- What does Vereenooghe SEW do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Vereenooghe SEW?
- Public limited company (NV).
- When was Vereenooghe SEW founded?
- On 15-10-1990.
- Is Vereenooghe SEW still active?
- Yes, Vereenooghe SEW is an active enterprise in the KBO register.
- How many employees does Vereenooghe SEW have?
- On average 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Vereenooghe SEW?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is Vereenooghe SEW profitable?
- In financial year 2025, Vereenooghe SEW made a loss of €68,317.
- Where can I find the annual accounts of Vereenooghe SEW?
- Vereenooghe SEW filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Vereenooghe SEW due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Vereenooghe SEW
Parent and group
Comparable companies
- APOTHEEK DERUMEAUXHarelbeke
- PHARMACIE DES CLOITRESAmay
- Apotheek P. HostensAntwerpen
- Pharmacie du progrèsCharleroi
- Apotheek ClessensAntwerpen
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.